Kivipelto, M., Helkala, E.L., Laasko, M.P., Haaninien, T., Alhainien, K., Soinenien, H., Tuomilehto, J. and Nissinen, A. (2001) Midlife Vascular Risk Factors and Alzheimer’s Disease in Later Life: Longitudinal, Population Based Study. British Medical Journal, 322, 1447-1451.
http://www.bmj.com/content/322/7300/1447.long

has been cited by the following article:

• TITLE: Exploring the Relationship between Statins and Alzheimer’s Disease: Can Statins Really Prevent Alzheimer’s Disease?

  AUTHORS: Massud Atta

  KEYWORDS: Statins, Alzheimer's Disease, Cholesterol, Dementia

  JOURNAL NAME: Advances in Alzheimer's Disease, Vol.4 No.1, February 17, 2015

  ABSTRACT: Alzheimer’s Disease is a common form of dementia that has neurological and behavioral repercussions. It is definitively diagnosed usually via an autopsy when the following three common markers are found: flattened cortical gray matter, Tau proteins and Beta-amyloid proteins. Patients suffering from Down Syndrome or Parkinson’s Disease are often associated with Alzheimer’s because they have 2 of the 3 precursors. There has been extensive research on Alzheimer’s and many studies claim that statins, a cholesterol-reducing drug, can help prevent Alzheimer’s Disease resulting in low levels of beta-amyloid. However, there are several reasons to believe that this is not true and in some cases statins may even induce AD. This paper will examine the pathology of Alzheimer’s, the effect of statins and whether it truly plays a role in preventing AD.